Novartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial

    American Journal of Transplantation, Vol. 17, Núm. 7, pp. 1853-1867